BIO-TECHNE Corp
TECH· Nasdaq
TECHBIO-TECHNE Corp
Filed Aug 25, 2021 · 10-K · 56 days after period end · 0001437749-21-020980
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $259.03M | $175.83M | $191.66M | $180.25M |
| Net Income | $14.96M | $58.85M | $16.46M | $41.70M |
| EPS Diluted | — | $1.48 | $0.42 | $1.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 25, 2021 · 56 d after period end
